Videos

Part 1: Big global trends that affect even the smallest research project 

• How the global economic situation will impact research of the future 
• The impact changing global demographics will have on research science
• How an ageing population will shift focus to lifestyle

Part 2: How will medical technology change the world – and thus our research?

• How clinical medical technology will drive advances in the lab
• Next-generation imaging and the future of microscopy
• Pharmacogenetics and it's ethical implications

Part 3: Big global trends that affect even the smallest research project 

• How the global economic situation will impact research of the future 
• The impact changing global demographics will have on research science
• How an ageing population will shift focus to lifestyle

Sartorius has developed a new polyethylene film and bioprocessing bags to facilitate the way towards the single-use facility of the future. For more click here.

INTEGRA has introduced a Row Dilution Plate Holder accessory for its VIAFLO 96 and 384 handheld benchtop pipettes. For more click HERE.

The new Bioer LifeECO gradient thermal cycler available in the UK from Alpha Laboratories brings high specifications and rapid, simple, touch-screen programming. The performance, particularly for thermal uniformity, thermal accuracy and thermal ramp rate is comparable to other more expensive PCR machines. For more information, click HERE.

When using air- and moisture-sensitive solvents and reagents, it is essential that these products are not only as dry as possible when you first use them, but they should remain dry in storage as well.

Through the innovative quadrant-style screw cap and specially designed septum, AcroSeal packaging ensures that you have access to high-quality and low moisture products every use, guaranteeing improved yield and consistency of your research experiments while reducing chemical waste. For more, click HERE.

According to recent research from the World Health Organization, 17.3 million people died from cardiovascular diseases globally in 2008, representing 30 per cent of all global deaths. The American Heart Association report, Forecasting the Future of Cardiovascular Disease in the United States, believes the real total direct medical costs of cardiovascular disease will reach $818.1 billion over the next three decades.

Now Dassault Systèmes has unveiled the world’s first 3D realistic simulation model of a whole human heart. 

For more, click HERE.

INTEGRA has published a new video testimonial in which researchers at the Institute for Clinical Chemistry at the Technical University of Munich (TUM) describe using the VACUSAFE Laboratory Aspiration System to provide simple, reliable and safe aspiration of cell culture supernatents. For more, click HERE.

An ‘in silico’ (computer simulated) model of the human body that will enable simulation of the effects of drugs and treatments on the human body is being developed by theUniversity of Sheffield-based Insigneo Institute. For more click HERE.

A study spearheaded by Scientific Director Giulio Superti-Furga at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences shows that fast-growing cancer cells are sensitive towards imbalances in the metabolism of nucleotides, the building blocks of DNA. 

This vulnerability can be exploited for a radically novel antitumour therapeutic approach. Not only did the researchers from Vienna, in a joint effort with colleagues from Oxford and Stockholm, identify the enzyme MTH1 as an Achilles heel of malignant tumour cells, but also, in a wonderful twist of fate, they discovered the chemical mirror image of an existing anti-cancer drug called crizotinib to be an efficient inhibitor of MTH1 activity. For more click HERE.

Scientists at Trinity College Dublin have made a major breakthrough with important implications for sufferers of the eye disease Age-Related Macular Degeneration (AMD), which can cause central blindness in sufferers.

The scientists found that a component of the immune system, ‘IL-18’, acts as a guardian of eyesight by suppressing the production of damaging blood vessels behind the retina at the back of the eye. For more click HERE